Marker Therapeutics, Inc. (MRKR)
1.65
-0.01
(-0.60%)
USD |
NASDAQ |
Feb 06, 16:00
1.66
+0.01
(+0.61%)
After-Hours: 20:00
Marker Therapeutics SG&A Expense (TTM) : 4.365M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| ADMA Biologics, Inc. | 96.37M |
| Viridian Therapeutics, Inc. | 77.23M |
| ACADIA Pharmaceuticals, Inc. | 523.36M |
| Kiniksa Pharmaceuticals International Plc | 180.03M |
| Neurocrine Biosciences, Inc. | 1.142B |